ICRA: Indian pharmaceutical industry continues to face headwinds; aggregate growth expected to come down to single digit
IIFL (India Infoline Group) | March 06, 2017
ICRA expects growth trajectory for Indian pharmaceutical industry to moderate on back of slowing growth from US, increased competition, and regulatory overhang along with base effect catching up.